Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

NCT03171818 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

PAIS
Neonatal Stroke
Perinatal Stroke

Interventions

DRUG: Darbepoetin Alfa
DRUG: Saline

Sponsor

UMC Utrecht

Collaborators

[object Object]
[object Object]